Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SAWAI GROUP HOLDINGS Co., Ltd. ( (JP:4887) ) just unveiled an update.
Sawai Group Holdings Co., Ltd. announced it will receive a significant dividend of 19,268 million yen from its subsidiary, Sawai Pharmaceutical Co., Ltd., which will be recorded in its non-consolidated financial statements for the fiscal year ending March 31, 2026. This transaction will not affect the consolidated financial statements, indicating a strategic financial maneuver to optimize internal financial structuring without altering the overall financial outlook for stakeholders.
The most recent analyst rating on (JP:4887) stock is a Sell with a Yen1650.00 price target. To see the full list of analyst forecasts on SAWAI GROUP HOLDINGS Co., Ltd. stock, see the JP:4887 Stock Forecast page.
More about SAWAI GROUP HOLDINGS Co., Ltd.
Sawai Group Holdings Co., Ltd. operates in the pharmaceutical industry, focusing primarily on the production and distribution of generic drugs. The company is a key player in the Japanese market, aiming to provide affordable and accessible medication solutions.
Average Trading Volume: 574,936
Technical Sentiment Signal: Sell
Current Market Cap: Yen174.4B
See more data about 4887 stock on TipRanks’ Stock Analysis page.